- $113.56m
- $95.58m
- $48.68m
- 68
- 66
- 52
- 66
Annual income statement for AMREP, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
C2019 April 30th | 2020 April 30th | 2021 April 30th | C2022 April 30th | 2023 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.8 | 18.8 | 40.1 | 58.9 | 48.7 |
| Cost of Revenue | |||||
| Gross Profit | 0.989 | 3.02 | 14.5 | 26.7 | 18.9 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 16 | 26.7 | 30.7 | 37.6 | 42.8 |
| Operating Profit | -3.23 | -7.96 | 9.35 | 21.3 | 5.83 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.17 | -7.63 | 10 | 21.6 | 7.64 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.46 | -5.9 | 7.39 | 15.9 | 21.8 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1.53 | -5.9 | 7.39 | 15.9 | 21.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.53 | -5.9 | 7.39 | 15.9 | 21.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.304 | -0.088 | 0.923 | 2.2 | 5.04 |